Drugs Channel
Topics & Medications
Quicklinks
Related Channels

Ibritumomab Drug Information

A healthcare provider may prescribe ibritumomab (Zevalin®) to help slow down the progression of a certain type of non-Hodgkin's lymphoma in adults. This medicine is administered into a vein via infusion by a healthcare provider in a healthcare setting.
 
While some people tolerate this medicine well, most people who receive ibritumomab will experience some type of side effect. Some of the most commonly reported reactions to this drug include fatigue, nausea, and abdominal (stomach) pain.
 
While it may be an effective medication, not everyone can use this drug. Information on ibritumomab should be discussed with your healthcare provider before starting treatment to minimize risks and to help ensure safe treatment. For example, you may not be able to use this medicine if you have an infection, if you are taking certain medications, or if you have certain allergies.
 
(For more information on this drug, click Ibritumomab. This article offers a complete overview of this medicine, including how it works, details on its safety and effectiveness, and how ibritumomab is administered.)
 

Ibritumomab Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.